Dr. rer.biol.hum. Roland Mergl

Dr. rer.biol.hum. Roland Mergl
Klinische Psychologie und Psychotherapie
+49 89 6004 3707
roland.mergl@unibw.de

Dr. rer.biol.hum. Roland Mergl

CURRICULUM VITAE – Kurzform

  • Seit 04/2019: Wissenschaftlicher Mitarbeiter am Institut für Klinische Psychologie und Psychotherapie an der Hochschule der Bundeswehr München
  • 01/2007-03/2019: Wissenschaftlicher Mitarbeiter an der Klinik für Psychiatrie und Psychotherapie im Universitätsklinikum Leipzig
  • Seit 2003: Wissenschaftlicher Mitarbeiter in der Zentrale des Kompetenznetzwerks "Depression-Suizidalität"
  • 07/2003: Promotion an der Ludwig-Maximilians-Universität (LMU) München
  • 10/1997-12/2006: Wissenschaftlicher Mitarbeiter in der Abteilung für Klinische Neurophysiologie der Klinik und Poliklinik für Psychiatrie und Psychotherapie der Ludwig-Maximilians-Universität München
  • 1991-1997: Studium der Psychologie (Diplom) an der Ludwig-Maximilians-Universität (LMU) München

 

FORSCHUNGSSCHWERPUNKTE

  • Suizidforschung
  • Screening und Therapie depressiver Störungen
  • Schlafforschung

 

AUSGEWÄHLTE PUBLIKATIONEN

Suizidforschung

  • Mergl, R., Havers, I., Althaus, D., Rihmer, Z., Schmidtke, A., Lehfeld, H., Niklewski, G. & Hegerl, U. (2010). Seasonality of suicide attempts: Association with gender. European Archives of Psychiatry and Clinical Neuroscience, 260, 393-400.
  • Hegerl, U., Mergl, R., Doganay, G., Reschke, K. & Rummel-Kluge, C. (2013). Why has the continuous decline in German suicide rates stopped in 2007? PLoS One, 8(8), e71589.
  • Szekely, A., Konkoly Thege, B., Mergl, R., Birkas, E., Rozsa, S., Purebl, G. & Hegerl, U. (2013). How to decrease suicide rates in both genders? An effectiveness study of a community-based intervention (EAAD). PLoS One, 8(9), e75081.
  • Mergl, R., Koburger, N., Heinrichs, K., Szekely, A., Toth, M.D., Coyne, J., Quintao, S., Arensman, E., Coffey, C., Maxwell, M., Värnik, A., van Audenhove, C., McDaid, D., Sarchiapone, M., Schmidtke, A., Genz, A., Gusmão, R. & Hegerl, U. (2015). What are reasons for the large gender differences in the lethality of suicidal acts? An epidemiological analysis in four European countries. PLoS One, 10(7), e0129062.

Screening und Therapie depressiver Störungen

  • Henkel, V., Mergl, R., Kohnen, R., Maier, W., Möller, H.-J. & Hegerl, U. (2003). Identifying depression in primary care: a comparison of different methods in a prospective cohort study. British Medical Journal, 326(7382), 200-201.
  • Mergl, R., Seidscheck, I., Allgaier, A.-K., Möller, H.-J., Hegerl, U. & Henkel, V. (2007). Depressive, anxiety and somatoform disorders in primary care: prevalence and recognition. Depression and Anxiety, 24, 185-195.
  • Mergl, R., Henkel, V., Allgaier, A.K., Kramer, D., Hautzinger, M., Kohnen, R., Coyne, J. & Hegerl, U. (2011). Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm. Psychotherapy and Psychosomatics, 80(1), 39-47.
  • Weitz, E.S., Hollon, S.D., Twisk, J., van Straten, A., Huibers, M.J., David, D., DeRubeis, R.J., Dimidjian, S., Dunlop, B.W., Cristea, I.A., Faramarzi, M., Hegerl, U., Jarrett, R.B., Kheirkhah, F., Kennedy, S.H., Mergl, R., Miranda, J., Mohr, D.C., Rush, A.J., Segal, Z.V., Siddique, J., Simons, A.D., Vittengl, J.R. & Cuijpers, P. (2015). Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy versus pharmacotherapy: An individual patient data meta-analysis. JAMA Psychiatry, 72(11), 1102-1109.
  • Vittengl, J.R., Jarrett, R.B., Weitz, E., Hollon, S.D., Twisk, J., Cristea, I., David, D., DeRubeis, R.J., Dimidjian, S., Dunlop, B.W., Faramarzi, M., Hegerl, U., Kennedy, S.H., Kheirkhah, F., Mergl, R., Miranda, J., Mohr, D.C., Rush, A.J., Segal, Z.V., Siddique, J., Simons, A.D., Cuijpers, P. (2016). Divergent outcomes in cognitive-behavioral therapy and pharmacotherapy for adult depression. American Journal of Psychiatry, 173(5), 481-490.
  • Mergl, R., Allgaier, A.-K., Hautzinger, M., Coyne, J.C., Hegerl, U. & Henkel, V. (2018). One-year follow-up of a randomized controlled trial of sertraline and cognitive behavior group therapy in depressed primary care patients (MIND study). The Journal of Affective Disorders, 230, 15-21.

Schlafforschung

  • Spada, J., Sander, C., Burkhardt, R., Häntzsch, M., Mergl, R., Scholz, M., Hegerl, U. & Hensch, T. (2014). Genetic association of objective sleep phenotypes with a functional polymorphism in the neuropeptides receptor gene. PLoS One, 9(6), e98789.
  • Ulke, C., Sander, C., Jawinski, P., Mauche, N., Huang, J., Spada, J., Wittekind, D., Mergl, R., Luck, T., Riedel-Heller, S., Hensch, T. & Hegerl, U. (2017). Sleep disturbances and upregulation of brain arousal during daytime in depressed versus non-depressed elderly subjects. World Journal of Biological Psychiatry, 18(80), 633-640.
  • Sander, C., Schmidt, J.M., Mergl, R., Schmidt, F.M. & Hegerl, U. (2018). Changes in brain arousal (EEG-vigilance) after therapeutic sleep deprivation in depressive patients and healthy controls. Scientific Reports, 8, 15087.